Skip to main content

Remote Job Finders (RJF)

In this episode of Denatured, Jennifer C. Smith-Parker speaks with Dr. Rob Monroe and Jennifer Fakish at Danaher Corporation. They discuss how antibody drug conjugates (ADCs) are transforming cancer care. With AI-powered pathology, doctors can now measure HER2 more precisely to match patients with the best treatments.
Digital Pathology, AI and the Future of ADCs and HER2 Cancer Treatment
Scroll to top